Literature DB >> 11367772

Using an improvement model to reduce adverse drug events in VA facilities.

W B Weeks1, P D Mills, R S Dittus, D C Aron, P B Batalden.   

Abstract

BACKGROUND: Adverse drug events cause significant morbidity and mortality in health care. Many adverse drug events are due to medication errors and are preventable. In 1999 and 2000 the Patient Safety Center of Inquiry collaborated with the Institute for Healthcare Improvement (IHI) to implement a quality improvement (QI) project designed to reduce medication errors within the Veterans Administration system.
METHODS: During a 6- to 9-month period, interdisciplinary teams that want to achieve much higher levels of performance work on a common aim, under the guidance of faculty, and come together for three 2-day educational and planning sessions. Between these sessions, teams implement some of the suggested changes, measure the results of those changes, and report back to the larger group.
RESULTS: During the formal project, teams collected allergy information on more than 20,000 veterans and averted 1,833 medication errors that had the potential to cause adverse events. At 6-month follow-up, the majority of teams remained intact, continued to collect data, and maintained their gains, approximately doubling the results obtained during the formal project. Half of the teams expanded their efforts to other settings, and one-third of the teams expanded beyond their original topics. Returns on investment in the QI effort were substantial.
CONCLUSIONS: The results suggest that gains made in organized QI efforts can be maintained for 6 months without additional external support or coaching if team structure and leadership support remain intact. Facilitators of QI efforts should focus on teams that are having difficulty learning new techniques. Finally, this effort appeared to generate cost savings.

Entities:  

Mesh:

Year:  2001        PMID: 11367772     DOI: 10.1016/s1070-3241(01)27021-7

Source DB:  PubMed          Journal:  Jt Comm J Qual Improv        ISSN: 1070-3241


  3 in total

1.  Surviving sepsis-but for how long?

Authors:  Peter Dodek
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

Review 2.  What is the value and impact of quality and safety teams? A scoping review.

Authors:  Deborah E White; Sharon E Straus; H Tom Stelfox; Jayna M Holroyd-Leduc; Chaim M Bell; Karen Jackson; Jill M Norris; W Ward Flemons; Michael E Moffatt; Alan J Forster
Journal:  Implement Sci       Date:  2011-08-23       Impact factor: 7.327

Review 3.  The economics of medicines optimization: policy developments, remaining challenges and research priorities.

Authors:  Rita Faria; Marco Barbieri; Kate Light; Rachel A Elliott; Mark Sculpher
Journal:  Br Med Bull       Date:  2014-09       Impact factor: 4.291

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.